Market Closed -
Nyse
04:00:02 2024-06-04 pm EDT
5-day change
1st Jan Change
66.2
USD
-0.75%
+1.08%
+24.23%
Globus Medical, Inc. Reaffirms Sales Guidance for the Full Year 2021
November 04, 2021 at 04:15 pm EDT
Globus Medical, Inc. reaffirms sales guidance for the full year 2021. The Company reaffirmed its full year 2021 guidance of $950 million in net sales.
BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating
May. 29
MT
Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60
May. 20
MT
Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing
May. 14
MT
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating
May. 13
MT
Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing
May. 10
MT
Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating
May. 09
MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon
May. 08
MT
Sector Update: Health Care
May. 08
MT
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards
May. 08
MT
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating
May. 08
MT
Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating
May. 08
MT
Globus Medical Q1 Non-GAAP Earnings, Sales Rise; 2024 Guidance Boosted
May. 07
MT
Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.
May. 07
CI
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q1 Revenue $606.7M, vs. Street Est of $589.6M
May. 07
MT
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q1 EPS $0.72, vs. Street Est of $0.57
May. 07
MT
Transcript : Globus Medical, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07
Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024
May. 07
CI
Globus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 07
CI
North American Morning Briefing : Stock Futures -2-
Mar. 19
DJ
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60
Mar. 18
MT
Globus Medical Insider Sold Shares Worth $405,730, According to a Recent SEC Filing
Mar. 05
MT
Atkore Insider Sold Shares Worth $2,195,228, According to a Recent SEC Filing
Mar. 05
MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating
Feb. 21
MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating
Feb. 21
MT
Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.
Feb. 21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
More about the company
Last Close Price
66.2
USD
Average target price
71.17
USD
Spread / Average Target
+7.50%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1